T5V-30897-24739
2 vaccinations
1 coded response
8 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 024 / MA
- Registered
- 2020-12-21
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-21
Registered in v-safe
-
2020-12-21
Dose 1 — Pfizer-BioNTech
- 2020-12-21
- 2020-12-23
- 2020-12-24
- 2020-12-27
- 2020-12-28
-
2021-01-04
Survey response — day 14, dose 1MedDRA: Fatigue, Headache, Oropharyngeal pain, Rhinorrhoea, SARS-CoV-2 test positive — Feeling: Fair · Be unable to workFree text: Rhinorrrhea, sore throat, headache, fatigue. Tested positive for covid (health care worker exposed in ED)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-04
-
2021-01-07
Call successfulDoes not wish to fill out VAERS report
-
2021-01-11
Dose 2 — Pfizer-BioNTech
- 2021-01-18
- 2021-02-26
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-21 | Pfizer-BioNTech | |
| 2 | 2021-01-11 | Pfizer-BioNTech |
Call center
1 call center case
1 successful
Free text
Release 1 — day 14, dose 1
Symptoms: Rhinorrrhea, sore throat, headache, fatigue. Tested positive for covid (health care worker exposed in ED)
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SD | Rhinorrhoea | ✓ | ✓ | ✓ |
| SD | SARS-CoV-2 antibody test positive | ○ | ○ | ○ |
| SD | SARS-CoV-2 test positive | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release